Fighting the stigmatization of monkeypox patients
When disease outbreaks occur, health experts are not only faced with the challenge of getting good information out to people – they also must battle […]
Pharma R&D
Preprints offer early insights into research
To stay competitive in R&D, it is critical to keep abreast of all the latest findings and innovations. Preprints are offering a new way to […]
Mobilizing against monkeypox
As the world continues to navigate Covid and its many strains, it would be an understatement to say that everyone is on high alert for […]
Reaxys User Day 2022: Researcher secrets in the spotlight
In April, Elsevier hosted the first Reaxys User Day to learn from expert users and share best practices. Attendees were also updated on how the […]
Taking on the Net Zero challenge at the government level
Life sciences companies are increasingly committing themselves to Net Zero goals, laying out plans for reaching zero emissions by 2050 or earlier. This is a […]
Pharma’s path to Net Zero
Pharma is seldom top of mind when thinking about the most polluting industries, but pharmaceutical industry operations are in fact responsible for a significant portion […]
Pharma can now track the most relevant patent info – fast and at scale
Since its initial release in January 2021, AI-fueled Patent Expansion in Reaxys has won the respect of pharmaceutical companies trying to stay ahead of their competitors by […]
Elsevier research partner Karin Verspoor nominated For Women in AI award
Network In recognition of her numerous research accomplishments, Professor Karin Verspoor is nominated for the prestigious Women in AI Award under the ‘AI in Innovation’ […]
How publishing can help address diversity in STEM
The issue of diversity in science, technology, engineering and mathematics is not a new topic, but it is one that needs to be continually addressed […]
The power of similarities to accelerate antiviral development for COVID-19
In April 2020, I wrote a blog post entitled “Exploiting similarities between SARS-CoV-2 and other viruses to accelerate vaccine and therapy development,” where I described […]
Data Science & AI amplifies your innovative drug R&D capabilities
If you work in Life Sciences & Health, you’re likely aware of what Data Science and AI can bring to the table when it comes […]
Emerging trends for pancreatitis in the scientific literature: a new report
Elsevier has just released the Emerging trends for pancreatitis in the scientific literature report, which identifies proteins and genes linked to pancreatitis. Elsevier’s Professional Services […]
Accelerating synthetic chemistry with a predictive retrosynthesis solution
In most aspects of life, we think of “endless possibilities” as a good thing. But in science, the wealth of possibilities can be daunting. Pharmaceutical […]
Representation matters: Diversity in leadership
Kumsal Bayazit, Elsevier CEO (Photo by Alison Bert) We have known for some time now that having more women in leadership positions benefits companies, including […]
Technology and empathy help make remote working a success for Elsevier
We at Elsevier were pleased to be one of five companies recognized for their ability to keep remote workers rooted in company culture in this […]
World Hepatitis Day 2021
Every 30 seconds, a person dies from a hepatitis-related illness. This terrible death toll is why the mantra for World Hepatitis Day (July 28) this […]
Collecting DNA from thin air
In a proof-of-concept study published this spring, researchers revealed that animal DNA can be collected from air sampling. The study’s authors have dubbed this DNA […]
An Update on Global Availability of COVID-19 Vaccines from Editor of The Lancet
In the U.S., the COVID-19 vaccine roll-out has moved at a strong pace, with about half of Americans now having received at least one shot. […]
4 Notable Life Sciences Trends from the Tech Trends Report
The Future Today Institute has released its 2021 Tech Trends Report (14th Annual Edition), a comprehensive report on strategic trends that it anticipates will affect […]
AI Disease Modeling Supports Precision Medicine for Cancer
Precision medicine has offered a lot of hope for the treatment of cancer, as it makes it possible to tackle the multi-faceted disease with a […]
HIV Vaccine Awareness Day
The global focus on the development and distribution of COVID-19 vaccines over the past year has been a reminder that there are still many other […]
Competitive Intelligence Gets a Boost with Reaxys Patent Expansion
The insights only found in patents can provide a crucial competitive advantage for innovative companies. In response to customer demand, Elsevier recently announced a major […]
FDA Introduces Data Modernization Action Plan
One of the frustrations of our Big Data era is that, despite the existence of an ever-growing wealth of valuable data, this data is often […]
Harris Poll Finds Large Boost in Pharma Industry Reputation
As the COVID-19 vaccine roll-out gains in intensity, it has become common to hear people toss out the names of pharmaceutical companies like Pfizer, Moderna […]
What Excites You Most About the Life Sciences Industry in 2021?
We have looked back at some of the biggest advances in 2020, but it’s a new year and time to look ahead, so we asked […]
What Were the Biggest Advances in Life Sciences in 2020?
As we settle into a new year, it’s always good to take a moment to consider what was accomplished in the previous one. That’s why […]
Workforce Upskilling in Pharma R&D
There is comfort in habits. There is comfort in the familiar. In normal times, change usually only occurs at a relatively slow pace. When we […]
Future of Pharma and RELX Reports Highlight Importance of Tech
Innovation in pharmaceutical R&D is inextricably tied to technological advancement. Two recently-released reports further highlight how much success in pharma is now being driven by […]
Elsevier to Work with Heel for Mechanism-based Drug Action Discovery
Elsevier, the data analytics business specialized in science and health, and Heel, a pharmaceutical company specialized in developing and manufacturing medicines made from natural ingredients, […]
Looking at Emerging Trends in Telemedicine
Telemedicine, once an intriguing proposition struggling to reach its potential, became an absolute necessity in 2020. In the early days of COVID-19, as medical centers […]
3D Printing Makes Medical Devices More Personal
Personalized medicine is a major trend in pharmaceutical R&D—and it’s transforming the way we think of therapeutics. Unlocking the secrets of the genome has made […]
3D Printing Makes Medical Devices More Personal
Personalized medicine is a major trend in pharmaceutical R&D—and it’s transforming the way we think of therapeutics. Unlocking the secrets of the genome has made […]
Pharma Industry Conferences Have Gone Online – Will They Stay There?
Back in 2014, writer Nick de Cent posed the question Is it time for the conference to go virtual? He interviewed digital healthcare consultant Len […]
Bringing Scalability Into Chemistry Modeling
Synthetic chemistry has been with us for centuries, but it is now entering a new frontier. Big data, AI and machine learning are unlocking a […]
International Life Science Awards Recognize Reaxys
The International Life Sciences Awards, an initiative from Global Health & Pharma Magazine (GHP) that is now in its fifth year, recognizes industry innovators – and […]
Model-based Strategy to Guide the Choice of Clinical Doses for ADC
Chemotherapy has been a powerful method for fighting cancer for decades. One of the most effective therapies available, it is also known for weakening the […]
How DNA-encoded Libraries Boost Drug Discovery
DNA-encoded libraries (DELs) have been gaining a lot of traction in hit finding and drug discovery in recent years. Regarded by some as a truly […]
Complimentary trend analysis report: Emerging trends in pancreatic cancer research
Pancreatic cancer sadly remains one of the most deadly cancers in existence, partly because it often goes undiagnosed until it has already metastasized. Finding new […]
Insights begin with clean, reusable data
Good data practices lead to better research outcomes. To learn more about why clean, reusable data is critical to R&D, take a look at this […]
Protected: Predicting Cancer Drug Combinations That Work
This content is password protected. To view it please enter your password below: Password:
Research Data Alliance Releases Guidelines for COVID-19 Data Sharing
The Research Data Alliance (RDA) has released its final version of the RDA COVID-19 Recommendations and Guidelines on data sharing for COVID-19, which covers four […]
To Be a Digital Pharma Player, You Need Data – Reusable Data
A new paper published in Drug Discovery Today finds that the pharmaceutical industry is in an “early mature” phase of using artificial intelligence in R&D, […]
The Dawn of a European Health Data Space – Challenges
The European data strategy aims to construct common data spaces for all, create a single EU market for data, and catalyze a dynamic data economy. […]
Treating Pharma Data as an Asset: moving from an application centric to an information-centric organization – presented by Dr. Martin Romacker, Roche
Pharma knows there is a need for clean, reusable, FAIR data to fuel effective machine learning-driven R&D – but driving effective information and knowledge management […]
The Dawn of a European Health Data Space – Opportunities
At the beginning of 2020, the European Commission introduced a “European strategy for data.” The document proposes to bolster and advance the data economy in […]
A Novelty Metric for Evaluating Journal Articles and Authors
Scientists have long looked for ways to measure the impact and value of their research. In this article we propose a new metric that attempts […]
Readying Your Workforce for Digital Transformation
Seeing it as key to innovation and competitive advantage, many businesses in the life sciences are learning to embrace digital transformation these days—in fact, with […]
5 Ways RWE is Fueling the Fight Against COVID-19
As we discussed in an earlier blog post, real-world evidence can bring value to every stage of the drug life cycle, from early discovery to […]
The FAIR Toolkit Helps Researchers with Data Challenges
Since the spread of COVID-19 was first reported, researchers of all types have mobilized to meet the challenges its causative agent, SARS-CoV-2, presents to the […]
How Are Regulatory Agencies Reacting to the Use of Real-World Evidence?
As we have discussed here previously, real-world data (RWD) and real-world evidence (RWE) offer many potential benefits in every stage of the drug discovery and […]
A Systems Thinking Approach for Pharma
Systems thinking asks scientists to look at the bigger picture and take a more holistic approach to their work. Systems thinkers consider how their field […]
